Deerfield Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Sell |
3,855,552
-5,287
| -0.1% | -$39.8K | 0.53% | 37 |
|
|
2025
Q1 | $29.2M | Buy |
3,860,839
+481,440
| +14% | +$3.64M | 0.58% | 39 |
|
|
2024
Q4 | $41.2M | Buy |
3,379,399
+99,399
| +3% | +$1.21M | 0.78% | 32 |
|
|
2024
Q3 | $54.9M | Sell |
3,280,000
-237
| -0% | -$3.97K | 0.82% | 27 |
|
|
2024
Q2 | $57.2M | Buy |
3,280,237
+2,141,706
| +188% | +$37.4M | 0.95% | 27 |
|
|
2024
Q1 | $19.4M | Buy |
+1,138,531
| New | +$19.4M | 0.34% | 54 |
|
|
2022
Q2 | – | Sell |
-375,585
| Closed | -$3.93M | – | 128 |
|
|
2022
Q1 | $3.93M | Sell |
375,585
-296,105
| -44% | -$3.1M | 0.09% | 90 |
|
|
2021
Q4 | $10.4M | Sell |
671,690
-372,310
| -36% | -$5.74M | 0.22% | 82 |
|
|
2021
Q3 | $23.6M | Hold |
1,044,000
| – | – | 0.46% | 63 |
|
|
2021
Q2 | $26.9M | Buy |
+1,044,000
| New | +$26.9M | 0.48% | 69 |
|